638 related articles for article (PubMed ID: 11187862)
21. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
Mannucci PM
Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
[TBL] [Abstract][Full Text] [Related]
22. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
Scandella D; Reyes H; Felch M; Sakurai Y
Haematologica; 2000 Oct; 85(10 Suppl):86-8. PubMed ID: 11187882
[TBL] [Abstract][Full Text] [Related]
23. Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.
Valentino LA; Recht M; Dipaola J; Shapiro AD; Pipe SW; Ewing N; Urgo J; Bullock T; Simmons M; Deguzman C
Haemophilia; 2009 May; 15(3):718-26. PubMed ID: 19298383
[TBL] [Abstract][Full Text] [Related]
24. Hemophilia factor VIII therapy. B- and T-cell tolerance: from basic concepts to clinical practice.
Saint-Remy JM
Haematologica; 2000 Oct; 85(10 Suppl):93-6. PubMed ID: 11187884
[TBL] [Abstract][Full Text] [Related]
25. Hemophilia treatment. Side effects during immune tolerance induction.
Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
[No Abstract] [Full Text] [Related]
26. Recent improvements in the clinical treatment of coagulation factor inhibitors.
Franchini M; Lippi G
Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
[TBL] [Abstract][Full Text] [Related]
27. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.
Auerswald G; Spranger T; Brackmann HH
Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531
[TBL] [Abstract][Full Text] [Related]
28. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
[TBL] [Abstract][Full Text] [Related]
29. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
30. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
31. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
32. Factor VIII inhibitors. Immune tolerance induction: is it cost effective? We know too little.
Aledort LM
Semin Thromb Hemost; 2000; 26(2):189-93. PubMed ID: 10919412
[TBL] [Abstract][Full Text] [Related]
33. Immunological and laboratory aspects of immune tolerance.
Kazatchkine M; Hoyer L
Vox Sang; 1996; 70 Suppl 1():52-9. PubMed ID: 8869470
[No Abstract] [Full Text] [Related]
34. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
35. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
[TBL] [Abstract][Full Text] [Related]
36. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
Singer ST; Addiego JE; Reason DC; Lucas AH
Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
[TBL] [Abstract][Full Text] [Related]
37. Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor.
Mariani G; Brackmann HH
Haematologica; 2001 Mar; 86(3):225-6. PubMed ID: 11255267
[No Abstract] [Full Text] [Related]
38. [Hemophilia A with factor VIII inhibitor].
Shima M
Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
[No Abstract] [Full Text] [Related]
39. Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.
Ciavarella N; Schiavoni M; Fasano A; Giliberti MG; Ettorre C; Stefanile C
Vox Sang; 1996; 70 Suppl 1():72-3. PubMed ID: 8869475
[No Abstract] [Full Text] [Related]
40. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]